Exact Mass: 309.159

Exact Mass Matches: 309.159

Found 100 metabolites which its exact mass value is equals to given mass value 309.159, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fluperlapine

6-fluoro-10-(4-methylpiperazin-1-yl)-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene

C19H20FN3 (309.1641)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

Fulvine

Isocromadurine

C16H23NO5 (309.1576)


   

Butenachlor

N-[[(E)-but-2-enoxy]methyl]-2-chloro-N-(2,6-diethylphenyl)acetamide

C17H24ClNO2 (309.1495)


   

ISOPROPALIN

ISOPROPALIN

C15H23N3O4 (309.1688)


CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10647; ORIGINAL_PRECURSOR_SCAN_NO 10642 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10600; ORIGINAL_PRECURSOR_SCAN_NO 10598 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10624; ORIGINAL_PRECURSOR_SCAN_NO 10622 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10736; ORIGINAL_PRECURSOR_SCAN_NO 10734 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10608; ORIGINAL_PRECURSOR_SCAN_NO 10605

   

Pro-Pro-Pro

Pro-Pro-Pro

C15H23N3O4 (309.1688)


A tripeptide composed of three L-proline units joined by peptide linkages.

   

Lysyltyrosine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688)


Lysyltyrosine is a dipeptide composed of lysine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tyrosyl-Lysine

6-Amino-2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}hexanoate

C15H23N3O4 (309.1688)


Tyrosyl-Lysine is a dipeptide composed of tyrosine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Metixene

1-Methyl-3-(thioxanthen-9-ylmethyl)- piperidine hydrochloride

C20H23NS (309.1551)


Metixene is only found in individuals that have used or taken this drug. It is a anticholinergic used as an anti-parkinson drug. [Wikipedia]Parkinsonism is thought to result from an imbalance between the excitatory (cholinergic) and inhibitory (dopaminergic) systems in the corpus striatum. The mechanism of action of centrally active anticholinergic drugs such as metixene is considered to relate to competitive antagonism of acetylcholine at muscarinic receptors in the corpus striatum, which then restores the balance. N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

N-Benzyl-9-(tetrahydro-2H-pyran-2-YL)adenine

N-Benzyl-9-(tetrahydro-2H-pyran-2-YL)adenine

C17H19N5O (309.159)


BAP9THP is a synthetic cytokinin derivative and a growth regulator. BAP9THP promotes chlorophyll retention (and senescence delay) in plant tissues exceptionally strongly, and growth of tobacco callus almost as strongly as 6-Benzylaminopurine (BAP). BAP9THP induces adventitious shoot formation ignificantly more strongly than N6-isopentenyladenine or Kinetin[1][2].

   

1,3-Dibenzylisoquinoline

Bis-benzyl-isoquinolines

C23H19N (309.1517)


   

Gevotroline

8-Fluoro-2,3,4,5-tetrahydro-2-[3-(3-pyridinyl)propyl]1H-pyrido[4,3-b]indole

C19H20FN3 (309.1641)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Pro-Pro-Pro

1-[1-(pyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C15H23N3O4 (309.1688)


   

Maybridge1_001542

Maybridge1_001542

C16H23NO5 (309.1576)


   

2-[(1-Benzyl-4-piperidyl)amino]-6-fluorobenzonitrile

2-[(1-Benzyl-4-piperidyl)amino]-6-fluorobenzonitrile

C19H20FN3 (309.1641)


   

Maybridge2_000507

Maybridge2_000507

C19H20FN3 (309.1641)


   

Sinapoylcholine

Sinapoylcholine

C16H23NO5 (309.1576)


   

crotaleschenine|Monocrotaline

crotaleschenine|Monocrotaline

C16H23NO5 (309.1576)


   

3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 5-benzyl, N-Ac

3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 5-benzyl, N-Ac

C16H23NO5 (309.1576)


   
   

N-coronafacoyl-L-threonine

N-coronafacoyl-L-threonine

C16H23NO5 (309.1576)


   

FLUPERLAPINE

FLUPERLAPINE

C19H20FN3 (309.1641)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

BAP9THP

N-Benzyl-9-(tetrahydro-2H-pyran-2-YL)adenine

C17H19N5O (309.159)


CONFIDENCE standard compound; INTERNAL_ID 1183; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8671; ORIGINAL_PRECURSOR_SCAN_NO 8666 CONFIDENCE standard compound; INTERNAL_ID 1183; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8607; ORIGINAL_PRECURSOR_SCAN_NO 8605 CONFIDENCE standard compound; INTERNAL_ID 1183; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8711; ORIGINAL_PRECURSOR_SCAN_NO 8710 CONFIDENCE standard compound; INTERNAL_ID 1183; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8730; ORIGINAL_PRECURSOR_SCAN_NO 8727 CONFIDENCE standard compound; INTERNAL_ID 1183; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8753; ORIGINAL_PRECURSOR_SCAN_NO 8748 CONFIDENCE standard compound; INTERNAL_ID 1183; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8722; ORIGINAL_PRECURSOR_SCAN_NO 8720 BAP9THP is a synthetic cytokinin derivative and a growth regulator. BAP9THP promotes chlorophyll retention (and senescence delay) in plant tissues exceptionally strongly, and growth of tobacco callus almost as strongly as 6-Benzylaminopurine (BAP). BAP9THP induces adventitious shoot formation ignificantly more strongly than N6-isopentenyladenine or Kinetin[1][2].

   
   
   
   

Sinapine

Sinapoylcholine

C16H23NO5 (309.1576)


   

Hydroxyanastrozole

Hydroxyanastrozole

C17H19ON5 (309.159)


   

metixene

Methixen [German];Methixene;Methixene hydrochloride;Metisene [DCIT];Metixene hydrochloride;Metixeno [INN-Spanish];Metixenum [INN-Latin]

C20H23NS (309.1551)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

Lys-tyr

6-amino-2-[2-amino-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C15H23N3O4 (309.1688)


A dipeptide formed from L-lysine and L-tyrosine residues.

   

Tyr-lys

2-(2,6-diaminohexanamido)-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688)


A dipeptide formed from L-tyrosine and L-lysine residues.

   
   

(S)-TERT-BUTYL 3-(((BENZYLOXY)CARBONYL)AMINO)-4-HYDROXYBUTANOATE

(S)-TERT-BUTYL 3-(((BENZYLOXY)CARBONYL)AMINO)-4-HYDROXYBUTANOATE

C16H23NO5 (309.1576)


   

Gefitinib impurity 2

Gefitinib impurity 2

C15H23N3O4 (309.1688)


   
   

(S)-Isopropyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate

(S)-Isopropyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate

C16H23NO5 (309.1576)


   

ditert-butyl(phenyl)phosphanium,tetrafluoroborate

ditert-butyl(phenyl)phosphanium,tetrafluoroborate

C14H23BF4P (309.1566)


   

Boc-D-aspartinol 4-Benzyl Ester

Boc-D-aspartinol 4-Benzyl Ester

C16H23NO5 (309.1576)


   

Boc-O-benzyl-D-threonine

Boc-O-benzyl-D-threonine

C16H23NO5 (309.1576)


   

Fmoc-(3S,4S)-AHPPA-OH

Fmoc-(3S,4S)-AHPPA-OH

C16H23NO5 (309.1576)


   

2,4,6-Triisopropylbenzenesulfonyl azide

2,4,6-Triisopropylbenzenesulfonyl azide

C15H23N3O2S (309.1511)


   

BOC-D-BETA-HOMOSER(BZL)-OH

BOC-D-BETA-HOMOSER(BZL)-OH

C16H23NO5 (309.1576)


   

Carbamic acid, N,N-3,5-pyridinediylbis-, C,C-bis(1,1-dimethylethyl) ester

Carbamic acid, N,N-3,5-pyridinediylbis-, C,C-bis(1,1-dimethylethyl) ester

C15H23N3O4 (309.1688)


   

o-tert-butyl-n-carbobenzoxy-l-serine methyl ester

o-tert-butyl-n-carbobenzoxy-l-serine methyl ester

C16H23NO5 (309.1576)


   

2-(4-tert-butoxycarbonylamino-butylamino)-nicotinic acid

2-(4-tert-butoxycarbonylamino-butylamino)-nicotinic acid

C15H23N3O4 (309.1688)


   

2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate

2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate

C15H23N3O4 (309.1688)


   

2-BENZYL-2-AZA-SPIRO[4.5]DECANE-4-CARBOXYLIC ACID HYDROCHLORIDE

2-BENZYL-2-AZA-SPIRO[4.5]DECANE-4-CARBOXYLIC ACID HYDROCHLORIDE

C17H24ClNO2 (309.1495)


   

5-tert-butyl 3-ethyl 1-methyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate

5-tert-butyl 3-ethyl 1-methyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate

C15H23N3O4 (309.1688)


   

Boc-O-ethyl-D-tyrosine

Boc-O-ethyl-D-tyrosine

C16H23NO5 (309.1576)


   

acetic acid,tert-butyl N-(5,6,7,8-tetrahydro-1,7-naphthyridin-3-yl)carbamate

acetic acid,tert-butyl N-(5,6,7,8-tetrahydro-1,7-naphthyridin-3-yl)carbamate

C15H23N3O4 (309.1688)


   

3-(2-morpholin-4-ylethylamino)-6-phenylpyridazine-4-carbonitrile

3-(2-morpholin-4-ylethylamino)-6-phenylpyridazine-4-carbonitrile

C17H19N5O (309.159)


   

(3S,4S)-3,4-DIAZIDO-1-(PHENYLMETHYL)PYRROLIDINE

(3S,4S)-3,4-DIAZIDO-1-(PHENYLMETHYL)PYRROLIDINE

C16H23NO5 (309.1576)


   

2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONIC ACID

C16H23NO5 (309.1576)


   

2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate

2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate

C16H23NO5 (309.1576)


   

4-([4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIEN-2-YL]METHYL)MORPHOLINE

4-([4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIEN-2-YL]METHYL)MORPHOLINE

C15H24BNO3S (309.157)


   

(2S)-3-(4-hydroxy-2,6-dimethylphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

(2S)-3-(4-hydroxy-2,6-dimethylphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

C16H23NO5 (309.1576)


   

4-((5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHEN-2-YL)METHYL)MORPHOLINE

4-((5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHEN-2-YL)METHYL)MORPHOLINE

C15H24BNO3S (309.157)


   

2-N-BOC-2-AMINOMETHYL-3-(4-METHOXYPHENYL)-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-(4-METHOXYPHENYL)-PROPIONIC ACID

C16H23NO5 (309.1576)


   

Boc-O-benzyl-L-beta-homoserine

Boc-O-benzyl-L-beta-homoserine

C16H23NO5 (309.1576)


   
   

Boc-Hse(Bzl)-OH

Boc-Hse(Bzl)-OH

C16H23NO5 (309.1576)


   
   

2-Methyl-3,4,5-triphenyl-1H-pyrrole

2-Methyl-3,4,5-triphenyl-1H-pyrrole

C23H19N (309.1517)


   

Boc-Thr(Bzl)-OH

Boc-Thr(Bzl)-OH

C16H23NO5 (309.1576)


   

1-[3-(2-Methoxy-5-nitrophenoxy)propyl]-4-methylpiperazine

1-[3-(2-Methoxy-5-nitrophenoxy)propyl]-4-methylpiperazine

C15H23N3O4 (309.1688)


   

1,3-Dibenzylisoquinoline

1,3-Dibenzylisoquinoline

C23H19N (309.1517)


   
   

N,O-Bis-(trimethylsilyl)phenylalanine

N,O-Bis-(trimethylsilyl)phenylalanine

C15H27NO2Si2 (309.158)


   

5-Deoxy-5-Piperidin-1-Ylthymidine

5-Deoxy-5-Piperidin-1-Ylthymidine

C15H23N3O4 (309.1688)


   

1-[(2s)-4-(5-Phenyl-1h-Pyrazolo[3,4-B]pyridin-4-Yl)morpholin-2-Yl]methanamine

1-[(2s)-4-(5-Phenyl-1h-Pyrazolo[3,4-B]pyridin-4-Yl)morpholin-2-Yl]methanamine

C17H19N5O (309.159)


   

Fructosyllysine(1+)

Fructosyllysine(1+)

C12H25N2O7+ (309.1662)


An amino-acid cation comprising fructosyllysine having a deprotonated carboxy group and both amino groups protonated; major species at pH 7.3.

   

Psicosyllysine(1+)

Psicosyllysine(1+)

C12H25N2O7+ (309.1662)


An amino-acid cation comprising psicosyllysine having a deprotonated carboxy group and both amino groups protonated; major species at pH 7.3.

   
   

N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide

N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide

C17H19N5O (309.159)


   

N-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methylene]-1H-indole-3-carbohydrazide

N-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methylene]-1H-indole-3-carbohydrazide

C17H19N5O (309.159)


   

1-[(2-Ethyl-4-hydroxy-4-methyl-1-oxopentyl)amino]-3-phenylthiourea

1-[(2-Ethyl-4-hydroxy-4-methyl-1-oxopentyl)amino]-3-phenylthiourea

C15H23N3O2S (309.1511)


   

2-chloro-N-[2-(2,2-dimethyl-4-phenyl-4-oxanyl)ethyl]acetamide

2-chloro-N-[2-(2,2-dimethyl-4-phenyl-4-oxanyl)ethyl]acetamide

C17H24ClNO2 (309.1495)


   

5-Fluoro-2-[(3S)-1-(2-methylbenzyl)-3-pyrrolidinyl]-1H-benzimidazole

5-Fluoro-2-[(3S)-1-(2-methylbenzyl)-3-pyrrolidinyl]-1H-benzimidazole

C19H20FN3 (309.1641)


   

6-[[(2-Isopropoxyphenyloxy)carbonyl]amino]hexanoic acid

6-[[(2-Isopropoxyphenyloxy)carbonyl]amino]hexanoic acid

C16H23NO5 (309.1576)


   

5-tert-butyl-2-methyl-N-quinoxalin-6-ylpyrazole-3-carboxamide

5-tert-butyl-2-methyl-N-quinoxalin-6-ylpyrazole-3-carboxamide

C17H19N5O (309.159)


   

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-cysteinamide

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-cysteinamide

C15H23N3O2S (309.1511)


   

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-serinamide

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-serinamide

C15H23N3O4 (309.1688)


   

(2S)-2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-3-hydroxy-2-methylpropanenitrile

(2S)-2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-3-hydroxy-2-methylpropanenitrile

C17H19N5O (309.159)


   

N-[[(E)-but-2-enoxy]methyl]-2-chloro-N-(2,6-diethylphenyl)acetamide

N-[[(E)-but-2-enoxy]methyl]-2-chloro-N-(2,6-diethylphenyl)acetamide

C17H24ClNO2 (309.1495)


   

Gevotroline

Gevotroline

C19H20FN3 (309.1641)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   
   

methyl 6-[cyclohex-2-en-1-yl(hydroxy)methyl]-4-hydroxy-6a-methyl-2h,3h,3ah-furo[2,3-c]pyrrole-6-carboxylate

methyl 6-[cyclohex-2-en-1-yl(hydroxy)methyl]-4-hydroxy-6a-methyl-2h,3h,3ah-furo[2,3-c]pyrrole-6-carboxylate

C16H23NO5 (309.1576)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-3-methylbutanamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-3-methylbutanamide

C15H23N3O4 (309.1688)


   

(1r,7s)-7-{[(2-hydroxyprop-2-enoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7s)-7-{[(2-hydroxyprop-2-enoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C16H23NO5 (309.1576)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-3-methylbutanamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-3-methylbutanamide

C15H23N3O4 (309.1688)


   

methyl (3ar,6r,6as)-6-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hydroxy-6a-methyl-2h,3h,3ah-furo[2,3-c]pyrrole-6-carboxylate

methyl (3ar,6r,6as)-6-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hydroxy-6a-methyl-2h,3h,3ah-furo[2,3-c]pyrrole-6-carboxylate

C16H23NO5 (309.1576)


   

6-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

6-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C16H23NO5 (309.1576)


   

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-hydroxybutanoic acid

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-hydroxybutanoic acid

C16H23NO5 (309.1576)


   

(2s,3r)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-hydroxybutanoic acid

(2s,3r)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-hydroxybutanoic acid

C16H23NO5 (309.1576)


   

(1r,4s,5r,6s,16r)-5-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4s,5r,6s,16r)-5-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C16H23NO5 (309.1576)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2,3,4-trimethyl-5-oxooxolane-3-carboxylate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2,3,4-trimethyl-5-oxooxolane-3-carboxylate

C16H23NO5 (309.1576)


   

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688)


   

5-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

5-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C16H23NO5 (309.1576)


   

(1s,12s,13r,14s)-15-ethylidene-7-hydroxy-13-(hydroxymethyl)-3,17λ⁵-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8,16-pentaen-17-ylium

(1s,12s,13r,14s)-15-ethylidene-7-hydroxy-13-(hydroxymethyl)-3,17λ⁵-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8,16-pentaen-17-ylium

[C19H21N2O2]+ (309.1603)


   

(1r,4r,5s,6r,16r)-6-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,4r,5s,6r,16r)-6-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C16H23NO5 (309.1576)